{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:31:21Z","timestamp":1792654281385,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/01.cad.0000236313.50833.ee","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T11:16:08Z","timestamp":1165490168000},"page":"23-28","source":"Crossref","is-referenced-by-count":370,"title":["Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood\u2013brain barrier"],"prefix":"10.1097","volume":"18","author":[{"given":"Hans-Joachim","family":"Stemmler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1200\/JCO.1996.14.3.737","article-title":"Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2\/neu-overexpressing metastatic breast cancer","volume":"14","author":"Baselga","year":"1996","journal-title":"J Clin Oncol"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/cncr.11436","article-title":"Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma","volume":"97","author":"Bendell","year":"2003","journal-title":"Cancer"},{"key":"R4-4-20210203","first-page":"218","article-title":"Central nervous system (CNS) metastases in women who receive trastuzumab for metastatic breast cancer (MBC).","volume":"21","author":"Chock","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6601970","article-title":"Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer","volume":"91","author":"Clayton","year":"2004","journal-title":"Br J Cancer"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D","article-title":"The natural history of breast cancer patients with brain metastases","volume":"44","author":"DiStefano","year":"1979","journal-title":"Cancer"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/cncr.20418","article-title":"The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma","volume":"101","author":"Lai","year":"2004","journal-title":"Cancer"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J Clin Oncol"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1524-4741.2003.09214.x","article-title":"Central nervous system progression during systemic response to trastuzumab, humanized anti-HER-2\/neu antibody, plus paclitaxel in a woman with refractory metastatic breast cancer","volume":"9","author":"Lindrud","year":"2003","journal-title":"Breast J"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejca.2003.09.018","article-title":"Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment","volume":"40","author":"Shmueli","year":"2004","journal-title":"Eur J Cancer"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.breast.2005.04.017","article-title":"Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer","volume":"15","author":"Stemmler","year":"2005","journal-title":"Breast"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B","article-title":"Central nervous system metastasis from breast carcinoma. Autopsy study","volume":"52","author":"Tsukada","year":"1983","journal-title":"Cancer"},{"key":"R13-4-20210203","first-page":"19361936","article-title":"High incidence of brain metastasis (BM) in patients on trastuzumab (H) for advanced breast cancer.","volume":"21","author":"Weitzen","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1200\/JCO.2000.18.11.2349","article-title":"Trastuzumab in CSF","volume":"18","author":"Pestalozzi","year":"2000","journal-title":"J Clin Oncol"},{"key":"R15-4-20210203","first-page":"4091","article-title":"Correction: meningeal carcinomatosis from breast carcinoma responsive to trastuzumab","volume":"19","author":"Pestalozzi","year":"2001","journal-title":"J Clin Oncol"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2001.19.13.3297","article-title":"Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab","volume":"19","author":"Baculi","year":"2001","journal-title":"J Clin Oncol"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1526-8209(11)70419-0","article-title":"Use of intrathecal trastuzumab in a patient with carcinomatous meningitis","volume":"2","author":"Laufman","year":"2001","journal-title":"Clin Breast Cancer"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.breast.2004.08.016","article-title":"Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer","volume":"14","author":"Altundag","year":"2005","journal-title":"Breast"},{"key":"R19-4-20210203","first-page":"683","article-title":"Changes in blood\u2013brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? [Review]","volume":"9","author":"van Vulpen","year":"2002","journal-title":"Oncol Rep"},{"key":"R20-4-20210203","first-page":"1373","article-title":"Application of intrathecal trastuzumab for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer","volume":"15","author":"Stemmler","year":"2006","journal-title":"Oncol Rep"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.cad.0000236313.50833.ee","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:10:42Z","timestamp":1786032642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200701000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.cad.0000236313.50833.ee","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}